Updates from #ASCO23: mRCC & the CONTACT03 Trial

This week’s episode is part 3 of 5 of a joint mini-series with The Fellow On Call. We will be recapping the current treatment of metastatic renal cell carcinoma (mRCC) and covering an oral abstract from the ASCO 2023 annual meeting,  the CONTACT03 Trial. We also cover subgroup analysis interpretation.